In contrast, TIM-3+ NKT cells obtained from chronic hepatitis B patients, showed an impaired capacity to produce IFN-γ and IL-4 upon stimulation, which was partially reverted by TIM-3 or PD-1 blocking agents [150]. The gene discussed is PDCD1; the disease is chronic hepatitis B virus infection.